It’s been a very productive year for disseminating results. In addition to many conference and other meeting posters and presentations, we are very proud to share that several MiND manuscripts have been accepted in 2021.
Dr Eratne published two big MiND papers this year. First, “Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer and frontotemporal disorders in clinical settings”, based on years of work from a large and fantastic group of people, in press at Alzheimer’s and Dementia. Second, “Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives”, in press at The Australian and New Zealand Journal of Psychiatry. Congratulations to Dr Eratne and all involved, thanks as always to all our wonderful collaborators, and we are excited about our ongoing work together, and many more great papers to come!
Huge congratulations also to Dr Nirbaan Walia for his publication recently accepted by Journal of the Neurological Sciences, “Cerebrospinal fluid neurofilament light predicts the rate of executive function decline in younger-onset dementia”, and Dr Blair Ney publishing his paper “The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt‐Jakob Disease Differ in Disease Duration”, in Molecular Neurobiology.
It has been a pleasure to have an increasing number of students join us, given The MiND Study’s aim to set up a platform to support diverse offshoots and sub-studies, on NfL and other biomarkers, and beyond biomarkers!
Well done to Michelle Chiu for passing her PhD pre-confirmation, and it will be great to have her on board The MiND Train, investigating neuropsychiatric symptoms, cognition, and biomarkers. Well done to Ryan Fleming for his work with Dr Cath Kaylor Hughes on developing a protocol to explore GP perceptions, facilitators and barriers to implementing tests in general practice, and finally well done to Brandon Cilia for completing his Honours project, investigating biomarkers and neuroimaging changes in psychiatric illness.
Well done to our very own Dr Matt Kang whose abstract was accepted for a lightning presentation at AAIC Neuroscience Next, on his study investigating the retrospective clinical utility of neurofilament light to reduce misdiagnosis for people with dementia and neuropsychiatric disorders in a real-world clinical setting. He also won the ‘Best Poster Award’ for his poster at the University of Melbourne Department of Psychiatry 2021 Annual Research Symposium – congratulations! Well done too to Michelle and Michael, for showcasing their great work at poster presentations at the same symposium, and to all three Ms for representing The MiND Study.
Several projects are underway, so please do get in touch if you’d like to learn more or get involved, have any interested students, if you have interest and availability to supervise, and as always if you have any ideas for collaborations or projects.
Once again congratulations to all the above, and all our collaborators for your help and support. We anticipate an even more productive 2022 and look forward to many more studies, sub-studies and offshoots, collaborations and publications together.
